FIELD: medicine.
SUBSTANCE: invention describes a method of determining a bronchial asthma control ratio in the patients with prescribed a background anti-inflammatory therapy with a combination of inhaled glucocorticosteroids and (long-acting 32-agonist) that involves determining the BA control by GINA 2006 criteria; in addition, the method measuring peripheral blood CD 20+ lymphocytes, and if the CD 20+ cell count is 15 or lower, the clinical course of BA is considered to be controlled, and if the CD 20+ cell count exceeds 15 then the clinical course is uncontrolled.
EFFECT: method enables the objective determination of the bronchial asthma control ratio that is necessary for correction of the antiasthmatic therapy.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING BRONCHIAL ASTHMA CONTROL RATIO | 2010 |
|
RU2440035C2 |
| METHOD OF ESTIMATING ANTIASTHMATIC THERAPY EFFICIENCY | 2010 |
|
RU2439570C2 |
| METHOD OF TREATING BRONCHIAL ASTHMA | 2010 |
|
RU2445082C2 |
| METHOD OF ACHIEVING CONTROL OVER BRONCHIAL ASTHMA | 2013 |
|
RU2571894C2 |
| METHOD OF MEDICAL REHABILITATION OF PATIENTS WITH PARTIALLY CONTROLLED MILD BRONCHIAL ASTHMA | 2017 |
|
RU2655543C1 |
| METHOD OF EVALUATING EFFECTIVENESS BASIC ANTI-INFLAMMATORY THERAPY OF BRONCHIAL ASTHMA IN CHILDREN | 2008 |
|
RU2354970C1 |
| METHOD OF PREVENTING DEVELOPMENT OF UNCONTROLLED BRONCHIAL ASTHMA FORMS INDUCED BY MANGANESE AND VANADIUM IMPACT IN CHILDREN OVER 5 YEARS OLD | 2014 |
|
RU2555341C1 |
| METHOD OF PREDICTING UNCONTROLLED COURSE OF SEVERE BRONCHIAL ASTHMA | 2011 |
|
RU2470582C1 |
| METHOD FOR PREVENTING PARTIALLY CONTROLLED BRONCHIAL ASTHMA CAUSED BY MANGANESE AND VANADIUM EXPOSURE IN CHILDREN AGED 5 AND OLDER | 2014 |
|
RU2546525C1 |
| METHOD OF PREDICTING RISK OF UNCONTROLLED BRONCHIAL ASTHMA IN OBESE CHILDREN | 2022 |
|
RU2805825C1 |
